International Conference on Hypertensive Kidney Disease and Management (ICHKDM - 26)

This session will explore the underlying mechanisms that contribute to hypertensive kidney disease, focusing on the interplay between hypertension and renal function. Researchers will present findings on vascular changes, glomerular injury, and the role of inflammation in disease progression.

This track will highlight recent advancements in the management of blood pressure among patients with kidney disease. Discussions will include novel pharmacological therapies, lifestyle interventions, and the use of technology in monitoring and treatment.

Participants will examine various methodologies for assessing renal function in hypertensive patients, including traditional and emerging biomarkers. The session aims to enhance understanding of how these techniques can inform clinical decision-making.

This session will delve into the cardiovascular risks associated with hypertensive kidney disease, emphasizing the bidirectional relationship between renal and cardiovascular health. Experts will discuss strategies for risk assessment and management in affected populations.

This track will present epidemiological studies that investigate the prevalence and trends of hypertension-related kidney disease globally. Researchers will share insights on demographic factors, risk stratification, and public health implications.

This session will focus on the importance of patient engagement and education in the management of hypertensive kidney disease. Presentations will cover strategies for improving adherence to treatment and enhancing patient outcomes.

This track will explore the impact of dietary interventions on hypertension and kidney health. Experts will discuss the role of specific nutrients, dietary patterns, and the importance of personalized nutrition in managing kidney disease.

This session will review current pharmacological treatments for managing hypertension in patients with kidney disease. Discussions will include the efficacy, safety, and potential side effects of various antihypertensive agents.

Participants will examine the potential of novel biomarkers for early detection and monitoring of hypertensive kidney disease. The session will highlight research on genetic, proteomic, and metabolomic approaches.

This track will focus on integrative strategies that combine conventional and complementary therapies for managing hypertensive kidney disease. Experts will discuss the evidence base for these approaches and their potential benefits.

This session will provide a platform for discussing future research priorities and innovative approaches in the field of hypertensive kidney disease. Participants will explore potential collaborations and funding opportunities to advance the field.